Evidence map›Paper›PMID 41933197›Full record

ArticleNature aging2026

Neuronal APOE4-induced early hippocampal network hyperexcitability in Alzheimer's disease pathogenesis.

Dennis R Tabuena, Sung-Soo Jang, Brian Grone, Oscar Yip, Emily A Aery Jones, Jessica Blumenfeld, Zherui Liang, Rajkamalpreet S Mann, Yaqiao Li, Deanna Necula and 10 more

Abstract read
In one paragraph

Article in Nature aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Microglia-to-neuron signaling linksProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Dennis R Tabuena *Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-1540-2331
Sung-Soo Jang *Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.
Brian Grone *Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.
Oscar YipGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-9096-7167
Emily A Aery JonesGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-8180-3267
Jessica BlumenfeldGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-5470-6901
Zherui LiangGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.
Rajkamalpreet S MannGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.
Yaqiao LiGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-9433-7346
Deanna NeculaGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.
Nicole KoutsodendrisGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-2761-1480
Antara RaoGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-1269-018X
Leonardo DingGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.ORCID http://orcid.org/0009-0005-7691-5244
Alex R ZhangGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.
Yanxia HaoGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.
Qin XuGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.
Seo Yeon YoonGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.
Samuel De LeonGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.
Yadong HuangGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA. yadong.huang@gladstone.ucsf.edu.ORCID http://orcid.org/0000-0002-5871-4589
Misha ZilberterGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA. misha.zilberter@gladstone.ucsf.edu.ORCID http://orcid.org/0000-0001-7164-8312

Funding

Project 4: Cross-species Dissection of Cellular Response to APOE Genotype and AD Pathology Using Single-cell Multi-omicsP01AG073082 · NIA · J. DAVID GLADSTONE INSTITUTES · PI HUANG, YADONG · 2021 to 2025
$23.4M
Neuronal ApoE Drives Selective Neurodegeneration in Alzheimer's DiseaseR01AG071697 · NIA · J. DAVID GLADSTONE INSTITUTES · PI HUANG, YADONG · 2021 to 2025
$4.1M
Study ApoE4's Effects on Hippocampal Network Activity in Alzheimer's DiseaseR01AG055682 · NIA · J. DAVID GLADSTONE INSTITUTES · PI HUANG, YADONG · 2017 to 2021
$3.6M
Apolipoprotein E4-related Electrophysiological and Metabolic Impairments in Aging and Alzheimer's DiseaseR01AG061150 · NIA · J. DAVID GLADSTONE INSTITUTES · PI ZILBERTER, MISHA YURI · 2019 to 2023
$3.3M
Study Alzheimer's Disease Protective APOE VariantsR01AG085468 · NIA · J. DAVID GLADSTONE INSTITUTES · PI YADONG HUANG, Misha Yuri Zilberter · 2024 to 2026
$2.8M
Exploring NOX2-Mediated Network Impairment and Neurodegeneration in Alzheimer's DiseaseR01AG087323 · NIA · J. DAVID GLADSTONE INSTITUTES · PI Misha Yuri Zilberter · 2025 to 2026
$1.7M
Targeting Nell2 and GABAergic Dysfunction to Mitigate APOE4-Driven Pathogenesis in Alzheimer's DiseaseR01AG092390 · NIA · J. DAVID GLADSTONE INSTITUTES · PI YADONG HUANG, Misha Yuri Zilberter · 2025 to 2026
$1.6M
Dynamics of Hippocampal Inputs in Alzheimer's DiseaseK99NS134734 · NINDS · STANFORD UNIVERSITY · PI AERY JONES, EMILY ASTER · 2023 to 2024
$246k
Investigation into transcriptomic control of dentate granule cell maturation and hyperexcitability in the apoE4 Alzheimer's Disease modelF32AG085961 · NIA · J. DAVID GLADSTONE INSTITUTES · PI TABUENA, DENNIS R · 2024 to 2025
$151k
NIA NIH HHS F32 AG085961NIA NIH HHS P01 AG073082NIA NIH HHS R01 AG055682NIA NIH HHS R01 AG061150NIA NIH HHS R01 AG071697NIA NIH HHS R01 AG085468NIA NIH HHS R01 AG087323NIA NIH HHS R01 AG092390NINDS NIH HHS K99 NS134734U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) F32AG085961U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) P01AG073082U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG055682U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG061150U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG071697U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG087323U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG092390
6 · The paper itself

Abstract

The full impact of APOE4 (apolipoprotein E4), the strongest genetic risk factor for Alzheimer's disease (AD), on neuronal and network function remains unclear, particularly during early preclinical stages of disease. Here we show that young APOE4 knockin (E4-KI) mice exhibit hippocampal region-specific network hyperexcitability that predicts later cognitive deficits. This early phenotype arises from cell-type-specific subpopulations of smaller, hyperexcitable neurons and is eliminated by selective removal of neuronal APOE4. With aging, E4-KI mice develop granule cell hyperexcitability, progressive inhibitory dysfunction and excitation-inhibition imbalance in the dentate gyrus. Single-nucleus RNA sequencing with multilevel gene filtering reveals age-dependent and cell-type-specific transcriptional changes and identifies candidate mediators of early neuronal hyperexcitability, including Nell2. Targeted CRISPR interference knockdown of Nell2 rescues abnormal excitability, implicating Nell2 as a contributor to APOE4-driven dysfunction. Together, these findings define molecular and circuit mechanisms linking neuronal APOE4-induced early network impairment to AD pathogenesis with aging.

Indexed as

Alzheimer DiseaseApolipoprotein E4HippocampusNerve NetNeuronsAgingAnimalsDentate GyrusDisease Models, AnimalMaleMiceMice, TransgenicApolipoprotein E4

Identifiers

PMID41933197
PMCPMC13099648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.